Siringo, M.; Baena, J.; Bote de Cabo, H.; Torres-Jiménez, J.; Zurera, M.; Zugazagoitia, J.; Paz-Ares, L.
Future Perspectives in the Second Line Therapeutic Setting for Non-Oncogene Addicted Non-Small-Cell Lung Cancer. Cancers 2023, 15, 5505.
https://doi.org/10.3390/cancers15235505
AMA Style
Siringo M, Baena J, Bote de Cabo H, Torres-Jiménez J, Zurera M, Zugazagoitia J, Paz-Ares L.
Future Perspectives in the Second Line Therapeutic Setting for Non-Oncogene Addicted Non-Small-Cell Lung Cancer. Cancers. 2023; 15(23):5505.
https://doi.org/10.3390/cancers15235505
Chicago/Turabian Style
Siringo, Marco, Javier Baena, Helena Bote de Cabo, Javier Torres-Jiménez, MarÃa Zurera, Jon Zugazagoitia, and Luis Paz-Ares.
2023. "Future Perspectives in the Second Line Therapeutic Setting for Non-Oncogene Addicted Non-Small-Cell Lung Cancer" Cancers 15, no. 23: 5505.
https://doi.org/10.3390/cancers15235505
APA Style
Siringo, M., Baena, J., Bote de Cabo, H., Torres-Jiménez, J., Zurera, M., Zugazagoitia, J., & Paz-Ares, L.
(2023). Future Perspectives in the Second Line Therapeutic Setting for Non-Oncogene Addicted Non-Small-Cell Lung Cancer. Cancers, 15(23), 5505.
https://doi.org/10.3390/cancers15235505
